AstraZeneca’s asthma drug fails main goal of COPD study

By Thomson Reuters Sep 17, 2025 | 1:14 AM

(Reuters) -AstraZeneca said on Wednesday that its asthma drug Fasenra failed the main goal of a late-stage study in patients with chronic obstructive pulmonary disease (COPD).

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Rashmi Aich)

Comments

Leave a Reply Cancel reply

You must be logged in to post a comment.

Two People Arrested After Gun Was Pointed During Argument

37m ago

North Side Church Destroyed In Fire

43m ago

300 Indiana National Guard Members Arrive In D.C.

50m ago belchonock / Depositphotos.com

Congo President Tshisekedi accuses Rwanda of violating peace deal

2h ago

Mirum Pharma to buy Bluejay Therapeutics for up to $820 million

2h ago

Australia to sign contract with Boeing for initial six 'Ghost Bat' defence drones, media report says

2h ago

Advertise with us »

WIKY Morning Show

6:00 AM - 10:00 AM

Now Playing

104.1 WIKY | Adult Contemporary Radio

Music Advisory Board

Tell us what you think about the songs we play!

AstraZeneca’s asthma drug fails main goal of COPD study

Comments

Leave a Reply Cancel reply

Current Weather

7-Day Forecast »

Music Advisory Board